Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuragenex is a healthcare company specializing in non-invasive, non-surgical, and non-opioid pain management treatments. The company operates a network of clinics that utilize Neurofunctional Pain Management, a proprietary approach combining electro-analgesia with specialized protocols to treat chronic pain conditions. Their primary goal is to provide long-term relief for patients suffering from musculoskeletal and neurological pain without the use of addictive medications or invasive procedures. Neuragenex focuses on restoring function and improving the quality of life for patients through evidence-based, regenerative-focused therapies. The company's treatment model is designed to address the root causes of pain rather than just masking symptoms, offering an alternative to traditional pharmaceutical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuragenex.